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Virus-like particles (VLP) are produced when the struc-
tural proteins of a non-enveloped virus are expressed in a
recombinant system. As a result, particles identical to the
native virus, but devoid of the viral genetic material, are
obtained. VLP are useful as vaccines, as carriers, and for
basic research. Their production represents a challenge, as
several proteins need to be simultaneously expressed and
assembled into a complex structure. Other aspects that
complicate process development include the difficulty of
accurately quantifying complete VLP, as well as possible
intermediates, and the difficulty of designing effective
purification procedures.
The versatility of the insect cell-baculovirus expression
vector system has made it one of the most frequently used
systems for the production of VLP. In this work, our recent
advances on the production of double-layered rotavirus-
like particles (dlRLP) by insect cells will be presented. The
use of a viral vector, such as the baculovirus, allows the
manipulation of the concentration of the recombinant
proteins by manipulating the multiplicity of infection,
allowing the production of rotavirus proteins at a stoichi-
ometry that maximizes protein assembly [3]. In vivo anal-
ysis of the accumulation of rotavirus proteins in insect
cells showed that assembly occurs intracellularly. How-
ever, differences in the intracellular distribution of rotavi-
rus proteins when they were individually expressed
suggest that the formation of RLP involve more than only
the contact between two proteins [2]. We will present in
vivo studies of the assembly or rotaviral proteins, where we
have identified and characterized the limiting steps and
intermediaries in the assembly process. Finally, tools for
the characterization and quantification of dlRLP and
assembly intermediates will be presented [1], along with
the development of a purification scheme for the 'prepar-
ative characterization of dlRLP. The results obtained and
the several strategies presented are an example of the char-
acteristics, limitations and specific requirements of ani-
mal cells in culture.
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